ROP
★★☆☆☆ PasstemplateRoper Technologies, Inc.
Technology · sector percentile 46
세션 움직임
$358.57
거래량 0.51× 평균
66/100 quant · tgt $439.43
RS60 -3.5% vs SPY · ADV$ 332.1M
세션 2026-10-07 · 스냅샷 — 실시간 호가 아님
직전 스캔 대비
2026-10-06 → 2026-10-07
참고용이며 매수/매도 신호가 아닙니다. 스캔 이력과 캐시된 뉴스·공시로 구성됩니다.
스냅샷 시세
세션 2026-10-07 · 스캔 2026-10-07 · 푸시 10-07 16:51 ET · 애프터아워 (오래됨)
시세 상세 보기시세 상세 숨기기
- 종가/스캔가
- $359.54
- 전일 종가
- $362.28
- 푸시 최신가
- $358.57 (오래됨) · 10-07 16:51 ET · 애프터아워
- 세션 시가
- $364.14
- 직전 세션 범위
- $357.48 – $365.24
- 52주 범위
- $305.19 – $517.59
- 세션 거래량
- 458,519
- 평균 거래량 (20일)
- 890,431
- 시가총액
- $35.56B
- PER (TTM)
- 14.98
- Forward PER
- 14.75
- 배당 수익률
- 0.98%
- 1년 목표가 추정
- $439.43
- 다음 실적
- 2026-10-22
Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes. 프리/애프터 시세는 유동성이 얇아 정규장과 다를 수 있습니다.
$1,000.00 넣었다면 지금
1년 전
$707.30
−29%
5년 전
$818.64
−18%
Price path only from cached daily closes (adjusted when available). Not dividends cash, fees, or advice.
시장 브리핑
선별된 요약입니다 — 매매 신호가 아닙니다. 헤드라인·링크는 제공된 그대로 표시됩니다.
- Roche (SWX:ROP) Stock Looks Discounted As Its 60% Run Continues
Roche Holding has delivered a powerful share price run over the last few years, which puts a bright spotlight on whether that market value still lines up with what the group earns. With a string of positive late stage trial results in oncology, neurology and renal disease, the question for you now is how much of that clinical momentum is already reflected in the price. Roche Holding has returned 59.8% over the past 3 years, so a lot of future expectations are already embedded in the current...
Yahoo · 2026-09-23
- Is Roche Holding (SWX:ROP) Undervalued Following Its Phase 3 IgA Nephropathy Win?
Roche Holding (SWX:ROP) is back in focus after partner Ionis reported that sefaxersen met the primary endpoint in the Phase 3 IMAgINATION trial for IgA nephropathy, delivering a statistically significant reduction in proteinuria compared with placebo. The latest clinical headlines come on top of a strong run for Roche Holding, with the share price up 8.32% over 90 days and 11.58% year to date. The 1-year total shareholder return of 44.02% points to momentum that has been building rather than...
Yahoo · 2026-09-23
- Is Roper Technologies Stock Underperforming the Dow?
Roper Technologies has notably underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Yahoo · 2026-09-07
Price Chart
Daily prices from cache
Loading price history…
AI Analysis
- Bull Thesis — ROP scores 66.4/100 (Pass) with revenue growth at 8.5% and a multi-factor profile supporting the current ranking.
- Risks — Key risks for ROP include valuation compression, sector rotation, and any deterioration in earnings momentum or balance-sheet leverage. Context: cached next earnings 2026-10-22; disclosure reasons form4_single_ambiguous, item_5_02.
- Target Upside — Consensus implied upside is 22.2%. Category 'Pass' suggests monitoring position sizing against the 100-point model thresholds.
Score History
30 days of scans. Daily batch adds the next weekday automatically while the API is running.
- DatePriceChgScoreRating
- 2026-10-07$359.54−$3.8066.4Pass
- 2026-10-06$363.34+$7.2567.0Pass
- 2026-10-05$356.09−$4.3865.2Pass
- 2026-10-02$360.47+$2.0565.6Pass
- 2026-10-01$358.41+$7.0965.4Pass
- 2026-09-30$351.32+$0.2365.6Pass
- 2026-09-29$351.09−$0.6967.5Pass
- 2026-09-28$351.78−$9.8268.0Pass
- 2026-09-25$361.60−$3.1968.8Pass
- 2026-09-24$364.79+$1.9370.0Watch
- 2026-09-23$362.87−$1.3370.0Watch
- 2026-09-22$364.20−$4.1970.2Watch
- 2026-09-21$368.39−$2.3871.3Watch
- 2026-09-18$370.77−$2.5470.9Watch
- 2026-09-17$373.31−$5.2571.3Watch
- 2026-09-16$378.55−$6.0970.9Watch
- 2026-09-15$384.65−$13.4472.3Watch
- 2026-09-14$398.08+$12.5172.5Watch
- 2026-09-11$385.57−$6.1972.4Watch
- 2026-09-10$391.76+$1.4672.5Watch
- 2026-09-09$390.30−$16.9872.3Watch
- 2026-09-08$407.28$0.0072.0Watch
- 2026-09-07$407.28−$15.0772.0Watch
- 2026-09-04$422.35+$6.5670.7Watch
- 2026-09-03$415.79−$2.5271.3Watch
- 2026-09-02$418.31−$6.3371.0Watch
- 2026-09-01$424.64−$1.5670.5Watch
- 2026-08-31$426.20+$3.5170.4Watch
- 2026-08-28$422.69+$9.4170.7Watch
- 2026-08-27$413.28—71.5Watch
Quant Breakdown
Short volume (FINRA)
Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.
- Short / total
- 61.9%
- vs 20d (z)
- -0.74
- Short vol
- 140,299
- Status
- ok
Squeeze pressure score
full40/100
- Short leg
- 28
- Call leg
- 70
- Activity
- 1.1
- Call vol share
- 70.1%
- PCR (vol)
- 0.43
- Call OI share
- 59.5%
- ATM IV
- 46.8%
FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.
공시 점수 (Disclosure)
캐시된 SEC 공시 기반 News / Insider / Earnings 규칙 다리 — 참고용이며, beat/miss나 매수 신호가 아닙니다.
공시 점수
-12
- News
- -12
- Insider
- 0
- Earnings
- 0
아래 신호는 캐시된 공시의 규칙 히트입니다 — Risk / Constructive / Attention. Attention은 상승 신호가 아닙니다. 링크된 칩은 SEC 원문으로 이동합니다.
Risk (−)
Attention (~)
Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.
실적 서프라이즈 (퀀트 맥락)
최근 퀀트 스캔에 캐시된 Yahoo/공개 펀더멘털 수치입니다 — 공시 이벤트 점수에 합산되지 않으며 매수 신호가 아닙니다. 최신 발표보다 늦을 수 있습니다.
최근 보고 서프라이즈 +2.1%
Filings & events
Recent SEC disclosures and earnings dates — context only, not a trade signal.
- Next earnings
- 2026-10-22yahoo_calendar
- Last earnings
- —
- SEC ↗42026-10-05
4
- SEC ↗8-K2026-10-01
8-K
- SEC ↗42026-09-17
4
- SEC ↗42026-09-17
4
- SEC ↗42026-09-17
4
- SEC ↗8-K2026-08-10
8-K
- SEC ↗10-Q2026-07-31
10-Q
- SEC ↗42026-07-27
4
- SEC ↗42026-07-27
4
- SEC ↗8-K2026-07-23
8-K
SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.